[
  {
    "ts": "2025-12-31T12:31:00+00:00",
    "headline": "Here's Why You Should Retain CONMED Stock in Your Portfolio Now",
    "summary": "CONMED gains momentum from high-margin platforms and supply-chain recovery, even as tariffs and dV5 adoption weigh on near-term margins.",
    "url": "https://finance.yahoo.com/news/heres-why-retain-conmed-stock-123100084.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d02843eb-3b55-38fd-9466-14969ec1b5db",
      "content": {
        "id": "d02843eb-3b55-38fd-9466-14969ec1b5db",
        "contentType": "STORY",
        "title": "Here's Why You Should Retain CONMED Stock in Your Portfolio Now",
        "description": "",
        "summary": "CONMED gains momentum from high-margin platforms and supply-chain recovery, even as tariffs and dV5 adoption weigh on near-term margins.",
        "pubDate": "2025-12-31T12:31:00Z",
        "displayTime": "2025-12-31T12:31:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rR6iZHXu8FRY2qc4ebuBNA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TXlDKOevAW4cJAnlMECSwQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-retain-conmed-stock-123100084.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-retain-conmed-stock-123100084.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CNMD"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-31T12:21:00+00:00",
    "headline": "How Is Boston Scientific's Cardiovascular Growth Path Shaping Up?",
    "summary": "BSX's $50B cardiovascular business aims to outpace market growth across EP, WATCHMAN, ICTx and more.",
    "url": "https://finance.yahoo.com/news/boston-scientifics-cardiovascular-growth-path-122100422.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "54040519-766a-32a0-bd8b-783812bd9f57",
      "content": {
        "id": "54040519-766a-32a0-bd8b-783812bd9f57",
        "contentType": "STORY",
        "title": "How Is Boston Scientific's Cardiovascular Growth Path Shaping Up?",
        "description": "",
        "summary": "BSX's $50B cardiovascular business aims to outpace market growth across EP, WATCHMAN, ICTx and more.",
        "pubDate": "2025-12-31T12:21:00Z",
        "displayTime": "2025-12-31T12:21:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientifics-cardiovascular-growth-path-122100422.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientifics-cardiovascular-growth-path-122100422.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]